Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • andreas.sjodin
    Member
    • Apr 2009
    • 27

    Postdoctoral Position in Colon Cancer Bioinformatics at Umeå University

    Within the large KAW project ”From genealogy to yeast; the search for colon cancer genes with a multidisciplinary approach” the aim is to identify mutations which give a predisposition for colon cancer and to understand why this is the case at the molecular level. There have been several attempts made to understand the genetics of the cancer cell through whole genome sequencing. However, by simply comparing mutations found in a tumor cell with those found in healthy tissue it is not possible to determine which mutation was the driving factor leading to the development of the tumor cell. Our unique approach is to analyze not the tumor cells but, instead, to look at healthy somatic cells in individuals that have developed familial colon cancer. The strength of this project also lies in the multidisciplinary competence of the participating investigators. Four research groups are involved with expertise in oncology, genetics, bioinformatics and DNA repair/replication systems. Mapping the genome using next generation sequencing technologies has created great opportunities to identify common, disease-causing mutations. These will in turn be analyzed in different model systems for understanding the molecular mechanisms of colon cancer.

    To this project, we are now searching for a person who can independently manage next generation sequencing data, develop methods and use existing software pipelines for organizing and analyzing such data from human samples. The position is full time and for a period of two years.

    Competence requirements

    To be eligible for the position you should have a PhD, or equivalent, in bioinformatics, biotechnology, genomics, computer science, statistics or related field, which is not more than three years old. You have documented good knowledge of at least one relevant scripting language (R, Python, Perl, C), and knowledge of the computational methods used in the analysis of Illumina/454/Solid sequencing data. Previous documented experience in working with human genomics data is a merit. Emphasis will also be placed on personal qualities such as collaboration and communication skills, analytical capacity and ability to take initiative. It is important that you have a good sense of initiative, and an ability to work independently. You will work in a multidisciplinary environment and, therefore, very good oral and written communication skills in English are required. Postdoctoral experience is a merit.

    The application

    The application should include (1) a Curriculum Vitae, (2) copies of relevant degree certificates and publications, (3) names and contact information to at least three reference persons and (4) a cover letter with a motivation. The application can be submitted either electronically (MS Word or PDF format) or in hard-copy (two copies) form.

    For further information please contact Adjunct Professor Beatrice Melin, Oncology Department, +46 (0)90-785 13 59, [email protected] or Professor Johan Trygg, Department of Chemistry, +46 (0)90-786 69 17, [email protected].

    Union information is available from SACO, +46-(0)90-786 53 65, SEKO, +46-(0)90-786 52 96 and ST, +46-(0)90-786 54 31.

    Your complete application, marked with reference number 315-1080-12, should be sent to [email protected] (state the reference number as subject) or to the Registrar, Umeå University, SE-901 87 Umeå, Sweden to arrive January 14, 2013 at the latest.

    We look forward to receiving your application!
    Last edited by andreas.sjodin; 12-15-2012, 01:12 AM.
  • andreas.sjodin
    Member
    • Apr 2009
    • 27

    #2
    The deadline is extended to after the Christmas break (January 14, 2013).

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Working...